Clinical Trial Update: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Bonviva (ibandronate) in women with postmenopausal osteoporosis who previously received Bonviva; the study has completed and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Bonviva (ibandronic acid)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Post-Menopausal Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2011-05-30